Enzymatica ABEnzymatica ABEnzymatica CEO steps downThe CEO of Lund-based Enzymatica AB, Claus Egstrand, is stepping down from his role. CFO Therese Filmersson will also leave her position. The process of finding their successors has already begun. more ➔
MC2 Therapeutics A/SMC2 Therapeutics A/SNew CEO – new chapterMC2 Therapeutics A/S, a Hørsholm-based pharmaceutical company focused on topical therapies in inflammatory skin conditions, announced the appointment of Trine Ahlgreen as Chief Executive Officer at … more ➔
Sibylla BiotechSibylla BiotechIndustry veteran appointedItalian Sibylla Biotech has appointed a new Chairman of the Board of Directors: Dieter Weinand, former President, CEO and Chairman of the Board of Bayer Pharmaceuticals AG. more ➔
Angeline VenturesAngelini VenturesReinforcement for Angelini VenturesDr Regina Hodits joined Angelini Ventures, the VC arm of Angelini Industries, in April as the new Managing Director. She will be based in Germany and lead the company’s international biotech investment … more ➔
4basebio4basebioNew Chief Commercial Officer on boardCambridge-based 4basebio PLC announced the appointment of Gabe Longoria as Chief Commercial Officer. more ➔
OSE TherapeuticsOSE ImmunotherapeuticsStrengthening developmentDr Sonya Montgomery joined OSE Immunotherapeutics SA, based in Nantes, France, as Chief Development Officer. more ➔
Nucleara LtdNuclera LtdNew non-executive director for NucleraCambridge-based biotechnology company Nuclera has appointed William J. Kullback to its board of directors as a non-executive director. more ➔
Single Use SupportSingle Use SupportNew CEO completes management teamKufstein-based Single Use Support appointed Darren Verlenden as CEO and strengthens leadership team. more ➔
BiosynthBiosynthNew CEO appointedMatt Gunnison was appointed as the new CEO of Biosynth, headquartered in Staad (CH). He started in November. more ➔
DiogenX SADiogenX SAExperienced CMO on boardThe French biotech company DiogenX is further strengthening its management team. In November, Dr Klara Owen was appointed as Chief Medical Officer. more ➔
Enzymatica AB
MC2 Therapeutics A/S
Sibylla Biotech
Angeline Ventures
4basebio
OSE Therapeutics
Nucleara Ltd
Single Use Support
Biosynth
DiogenX SA